Loading organizations...
Loading organizations...
Develops cancer treatments through tumor microenvironment analysis.
Novasenta has raised $60.0M across 2 funding rounds.
Novasenta has raised $60.0M in total across 2 funding rounds.
Novasenta has raised $60.0M in total across 2 funding rounds.
Novasenta's investors include Jeanne Cunicelli, UPMC.
Novasenta has raised $60.0M across 2 funding rounds. Most recently, it raised $40.0M Series A in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2022 | $40.0M Series A | Jeanne Cunicelli | |
| Aug 24, 2021 | $20.0M Seed | UPMC |